Cryoport, Inc. (CYRX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. on December 19, 2019, reporting an event that occurred on December 14, 2019. The filing details the mandatory conversion of a convertible note into common stock.
Key Financial Metrics and Transaction Details
The filing reports the conversion of a convertible note issued to Petrichor Opportunities Fund I LP. The transaction involved the following amounts:
- Principal Amount Converted: $15,000,000
- Accrued Interest Converted: $417,500
- Total Shares Issued: 1,172,305 shares of common stock
- Conversion Rate (Principal): $13.11 per share
- Conversion Rate (Interest): Approximately $14.837 per share (based on the 15-day VWAP prior to conversion)
The filing does not provide data on revenue, profit, cash flow, margins, or overall liquidity positions for the period.
Material Changes
The primary material change is the reduction of debt obligations and the corresponding increase in outstanding common stock. The $15,000,000 principal and $417,500 accrued interest were fully extinguished in exchange for equity.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure of the transaction. The issuance of shares relied on the exemption set forth in Section 3(a)(9) of the Securities Act of 1933.
Key Facts for Investor Verification
- Verify the total number of outstanding shares post-conversion to assess dilution impact.
- Confirm the removal of the $15,417,500 debt obligation from the company's balance sheet.
- Review the terms of the original note issued on December 14, 2018, and the amendment from July 9, 2019, to understand the mandatory conversion triggers.
- Check subsequent filings for any registration rights or resale restrictions on the 1,172,305 newly issued shares.